Differentiation of oligodendrocyte progenitor cells from human embryonic stem cells on vitronectin-derived synthetic peptide acrylate surface

Stem Cells and Development

Volumn 22, Issue 10, 2013, Pages 1497-1505

  Li, Yan ^a,b   Gautam, Archna ^a   Yang, Jiwei ^a   Qiu, Liqun ^a   Melkoumian, Zara ^c   Weber, Jennifer ^c   Telukuntla, Lavanya ^a   Srivastava, Rashi ^a   Whiteley, Erik M ^a   Brandenberger, Ralph ^a  

^a GERON CORPORATION   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

^c Corning Incorporated ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NESTIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEOCHONDROITIN SULFATE; SYNTHETIC PEPTIDE; SYNTHETIC PEPTIDE ACRYLATE SURFACE; UNCLASSIFIED DRUG; VITRONECTIN;

ARTICLE; CELL ADHESION; CELL EXPANSION; CELL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACRYLATES; AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; HUMANS; MOLECULAR SEQUENCE DATA; OLIGODENDROGLIA; PEPTIDES; SURFACE PROPERTIES; VITRONECTIN;

EID: 84877348598     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0508     Document Type: Article

References (48)

1. Fehlings MG, R Vawda. (2011). Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics 8:704-720
2. Rowland JW, GW Hawryluk, B Kwon, MG Fehlings. (2008). Current status of acute spinal cord injury pathophysiology, emerging therapies: promise on the horizon. Neurosurg Focus 25:E2
3. Talac R, JA Friedman, MJ Moore, L Lu, E Jabbari, AJ Windebank, BL Currier, MJ Yaszemski. (2004). Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies. Biomaterials 25:1505-1510
4. Watson RA, TM Yeung. (2011). What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury? BMC Neurol 11:113
5. Ronaghi M, S Erceg, V Moreno-Manzano, M Stojkovic. (2010). Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 28:93-99
6. Wright KT, W El Masri, A Osman, J Chowdhury, WE Johnson. (2011). Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms, clinical applications. Stem Cells 29:169-178
7. Nistor GI, MO Totoiu, N Haque, MK Carpenter, HS Keirstead. (2005). Human embryonic stem cells differentiate into oligodendrocytes in high purity, myelinate after spinal cord transplantation. Glia 49:385-396
8. Sundberg M, H Skottman, R Suuronen, S Narkilahti. (2010). Production, isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium. Stem Cell Res 5:91-103
9. Pouya A, L Satarian, S Kiani, M Javan, H Baharvand. (2011). Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors, transplantation in a rat model of optic chiasm demyelination. PLoS One 6: e27925
10. Keirstead HS, G Nistor, G Bernal, M Totoiu, F Cloutier, K Sharp, O Steward. (2005). Human embryonic stem cellderived oligodendrocyte progenitor cell transplants remyelinate, restore locomotion after spinal cord injury. J Neurosci 25:4694-4705
11. Kerr CL, BS Letzen, CM Hill, G Agrawal, NV Thakor, JL Sterneckert, JD Gearhart, AH All. (2010). Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int J Neurosci 120:305-313
12. Sharp J, J Frame, M Siegenthaler, G Nistor, HS Keirstead. (2010). Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 28:152-163
13. Wirth E, 3rd, JS Lebkowski, K Lebacqz. (2011). Response to Frederic Bretzner et al. Target populations for firstin-human embryonic stem cell research in spinal cord injury. Cell Stem Cell 8:476-478
14. Geron Corporation: Press Release Nov14(2011). Geron to Focus on its Novel Cancer Programs. http://ir.geron.com/phoenix.zhtml?c=67323&p=irol- newsArticle&ID=1635764&highlight. Accessed Nov 06, 2012
15. Hu J, L Deng, X Wang, XM Xu. (2009). Effects of extracellular matrix molecules on the growth properties of oligodendrocyte progenitor cells in vitro. J Neurosci Res 87: 2854-2862
16. Hu BY, ZW Du, SC Zhang. (2009). Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 4:1614-1622
17. Sundberg M, A Hyysalo, H Skottman, S Shin, M Vemuri, R Suuronen, S Narkilahti. (2011). A xeno-free culturing protocol for pluripotent stem cell-derived oligodendrocyte precursor cell production. Regen Med 6:449-460
18. Kang SM, MS Cho, H Seo, CJ Yoon, SK Oh, YM Choi, DW Kim. (2007). Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 25:419-424
19. Hughes CS, LM Postovit, GA Lajoie. (2010). Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10:1886-1890
20. Sher F, V Balasubramaniyan, E Boddeke, S Copray. (2008). Oligodendrocyte differentiation, implantation: new insights for remyelinating cell therapy. Curr Opin Neurol 21:607-614
21. O'Meara RW, JP Michalski, R Kothary. (2011). Integrin signaling in oligodendrocytes, its importance in CNS myelination. J Signal Transduct 2011:354091
22. Gil JE, DH Woo, JH Shim, SE Kim, HJ You, SH Park, SH Paek, SK Kim, JH Kim. (2009). Vitronectin promotes oligodendrocyte differentiation during neurogenesis of human embryonic stem cells. FEBS Lett 583:561-567
23. Xu C, MS Inokuma, J Denham, K Golds, P Kundu, JD Gold, MK Carpenter. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19: 971-974
24. Ludwig TE, ME Levenstein, JM Jones, WT Berggren, ER Mitchen, JL Frane, LJ Crandall, CA Daigh, KR Conard, et al. (2006). Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185-187
25. Stojkovic P, M Lako, S Przyborski, R Stewart, L Armstrong, J Evans, X Zhang, M Stojkovic. (2005). Human-serum matrix supports undifferentiated growth of human embryonic stem cells. Stem Cells 23:895-902
26. Amit M, C Shariki, V Margulets, J Itskovitz-Eldor. (2004). Feeder layer-, serum-free culture of human embryonic stem cells. Biol Reprod 70:837-845
27. Li Y, S Powell, E Brunette, J Lebkowski, R Mandalam. (2005). Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 91:688-698
28. Rowland TJ, LM Miller, AJ Blaschke, EL Doss, AJ Bonham, ST Hikita, LV Johnson, DO Clegg. (2010). Roles of integrins in human induced pluripotent stem cell growth on Matrigel, vitronectin. Stem Cells Dev 19:1231-1240
29. Chen G, DR Gulbranson, Z Hou, JM Bolin, V Ruotti, MD Probasco, K Smuga-Otto, SE Howden, NR Diol, et al. (2011). Chemically defined conditions for human iPSC derivation, culture. Nat Methods 8:424-429
30. Miyazaki T, S Futaki, K Hasegawa, M Kawasaki, N Sanzen, M Hayashi, E Kawase, K Sekiguchi, N Nakatsuji, H Suemori. (2008). Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells. Biochem Biophys Res Commun 375:27-32
31. Prowse AB, MR Doran, JJ Cooper-White, F Chong, TP Munro, J Fitzpatrick, TL Chung, DN Haylock, PP Gray, EJ Wolvetang. (2010). Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media. Biomaterials 31:8281-8288
32. Rodin S, A Domogatskaya, S Strom, EM Hansson, KR Chien, J Inzunza, O Hovatta, K Tryggvason. (2010). Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 28:611-615
33. Braam SR, L Zeinstra, S Litjens, D Ward-van Oostwaard, S van den Brink, L van Laake, F Lebrin, P Kats, R Hochstenbach, et al. (2008). Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell selfrenewal via alphavbeta5 integrin. Stem Cells 26:2257-2265
34. Derda R, S Musah, BP Orner, JR Klim, L Li, LL Kiessling. (2010). High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells. J Am Chem Soc 132:1289-1295
35. Irwin EF,RGupta,DCDashti andKE Healy. (2011). Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cells. Biomaterials 32:6912-6919
36. Klim JR, L Li, PJ Wrighton, MS Piekarczyk, LL Kiessling. (2010). A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods 7:989-994
37. Villa-Diaz LG, H Nandivada, J Ding, NC Nogueirade-Souza, PH Krebsbach, KS O'Shea, J Lahann, GD Smith. (2010). Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol 28:581-583
38. Melkoumian Z, JL Weber, DM Weber, AG Fadeev, Y Zhou, P Dolley-Sonneville, J Yang, L Qiu, CA Priest, et al. (2010). Synthetic peptide-acrylate surfaces for long-term selfrenewal, cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol 28:606-610
39. Hoffman LM, MK Carpenter. (2005). Characterization, culture of human embryonic stem cells. Nat Biotechnol 23:699-708
40. Allegrucci C, LE Young. (2007). Differences between human embryonic stem cell lines. Hum Reprod Update 13:103-120
41. Zhang YW, J Denham, RS Thies. (2006). Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev 15:943-952
42. Weber JL, P Dolley-Sonneville, DM Weber, AG Fadeev, Y Zhou, J Yang, CA Priest, R Brandenberger, Z Melkoumian. (2010). Corning Synthemax Surface: a tool for feeder-free, xeno-free culture of human embryonic stem cells. Nat Methods 7:an6-an7
43. Ogawa S, Y Tokumoto, J Miyake, T Nagamune. (2011). Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells. In Vitro Cell Dev Biol Anim 47:464-469
44. Blaschuk KL, EE Frost, C ffrench-Constant. (2000). The regulation of proliferation, differentiation in oligodendrocyte progenitor cells by alphaV integrins. Development 127:1961-1969
45. Brafman DA, CW Chang, A Fernandez, K Willert, S Varghese, S Chien. (2010). Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials 31:9135-9144
46. Mahlstedt MM, D Anderson, JS Sharp, R McGilvray, MD Munoz, LD Buttery, MR Alexander, FR Rose, C Denning. (2010). Maintenance of pluripotency in human embryonic stem cells cultured on a synthetic substrate in conditioned medium. Biotechnol Bioeng 105:130-140
47. Liu Y, X Wang, DS Kaufman, W Shen. (2011). A synthetic substrate to support early mesodermal differentiation of human embryonic stem cells. Biomaterials 32:8058-8066
48. Serra M, C Brito, C Correia, PM Alves. (2012). Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol 30:350-359